COX-2 inhibitors (aspirin, nonsteroidal anti-inflammatory drugs, and celecoxib) have been shown to be effective in preventing colorectal cancer [20]–[22], which suggests a pathogenic role for COX in colonic tumorigenesis. Here, PTGS2 is linked to colorectal cancer.